<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">36864043</PMID><DateCompleted><Year>2023</Year><Month>03</Month><Day>10</Day></DateCompleted><DateRevised><Year>2023</Year><Month>03</Month><Day>10</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2059-3635</ISSN><JournalIssue CitedMedium="Internet"><Volume>8</Volume><Issue>1</Issue><PubDate><Year>2023</Year><Month>Mar</Month><Day>03</Day></PubDate></JournalIssue><Title>Signal transduction and targeted therapy</Title><ISOAbbreviation>Signal Transduct Target Ther</ISOAbbreviation></Journal><ArticleTitle>Autoantibodies targeting to GPER1 promote monocyte cytokines production and inflammation in systemic lupus erythematosus.</ArticleTitle><Pagination><StartPage>93</StartPage><MedlinePgn>93</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">93</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41392-022-01294-3</ELocationID><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Zhang</LastName><ForeName>Xinwei</ForeName><Initials>X</Initials><Identifier Source="ORCID">0000-0002-1582-2483</Identifier><AffiliationInfo><Affiliation>Department of Rheumatology and Clinical Immunology, the First Affiliated Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen, 361000, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Xiamen Municipal Clinical Research Center for Immune Diseases, Xiamen, 361000, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Xiamen Key Laboratory of Rheumatology and Clinical Immunology, Xiamen, 361000, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Qian</LastName><ForeName>Hongyan</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Rheumatology and Clinical Immunology, the First Affiliated Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen, 361000, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Xiamen Municipal Clinical Research Center for Immune Diseases, Xiamen, 361000, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Xiamen Key Laboratory of Rheumatology and Clinical Immunology, Xiamen, 361000, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Yangchun</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Rheumatology and Clinical Immunology, the First Affiliated Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen, 361000, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Xiamen Municipal Clinical Research Center for Immune Diseases, Xiamen, 361000, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Xiamen Key Laboratory of Rheumatology and Clinical Immunology, Xiamen, 361000, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Yuanhui</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Rheumatology and Clinical Immunology, the First Affiliated Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen, 361000, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Xiamen Municipal Clinical Research Center for Immune Diseases, Xiamen, 361000, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Xiamen Key Laboratory of Rheumatology and Clinical Immunology, Xiamen, 361000, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sun</LastName><ForeName>Yuechi</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Rheumatology and Clinical Immunology, the First Affiliated Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen, 361000, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Xiamen Municipal Clinical Research Center for Immune Diseases, Xiamen, 361000, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Xiamen Key Laboratory of Rheumatology and Clinical Immunology, Xiamen, 361000, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>He</LastName><ForeName>Yan</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Rheumatology and Clinical Immunology, the First Affiliated Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen, 361000, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Xiamen Municipal Clinical Research Center for Immune Diseases, Xiamen, 361000, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Xiamen Key Laboratory of Rheumatology and Clinical Immunology, Xiamen, 361000, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Shiju</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Rheumatology and Clinical Immunology, the First Affiliated Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen, 361000, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Xiamen Municipal Clinical Research Center for Immune Diseases, Xiamen, 361000, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Xiamen Key Laboratory of Rheumatology and Clinical Immunology, Xiamen, 361000, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shi</LastName><ForeName>Guixiu</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Rheumatology and Clinical Immunology, the First Affiliated Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen, 361000, China. gshi@xmu.edu.cn.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Xiamen Municipal Clinical Research Center for Immune Diseases, Xiamen, 361000, China. gshi@xmu.edu.cn.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Xiamen Key Laboratory of Rheumatology and Clinical Immunology, Xiamen, 361000, China. gshi@xmu.edu.cn.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Yuan</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Rheumatology and Clinical Immunology, the First Affiliated Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen, 361000, China. liuyuan@xmu.edu.cn.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Xiamen Municipal Clinical Research Center for Immune Diseases, Xiamen, 361000, China. liuyuan@xmu.edu.cn.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Xiamen Key Laboratory of Rheumatology and Clinical Immunology, Xiamen, 361000, China. liuyuan@xmu.edu.cn.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016422">Letter</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>03</Month><Day>03</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Signal Transduct Target Ther</MedlineTA><NlmUniqueID>101676423</NlmUniqueID><ISSNLinking>2059-3635</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D001323">Autoantibodies</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011960">Receptors, Estrogen</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D043562">Receptors, G-Protein-Coupled</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001323" MajorTopicYN="Y">Autoantibodies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007249" MajorTopicYN="N">Inflammation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008180" MajorTopicYN="Y">Lupus Erythematosus, Systemic</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009000" MajorTopicYN="N">Monocytes</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011960" MajorTopicYN="N">Receptors, Estrogen</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D043562" MajorTopicYN="N">Receptors, G-Protein-Coupled</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>8</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>12</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>11</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>3</Month><Day>2</Day><Hour>23</Hour><Minute>14</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>3</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>3</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36864043</ArticleId><ArticleId IdType="pmc">PMC9981603</ArticleId><ArticleId IdType="doi">10.1038/s41392-022-01294-3</ArticleId><ArticleId IdType="pii">10.1038/s41392-022-01294-3</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Lou H, Ling GS, Cao X. Autoantibodies in systemic lupus erythematosus: from immunopathology to therapeutic target. J. Autoimmun. 2022;132:102861. doi: 10.1016/j.jaut.2022.102861.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaut.2022.102861</ArticleId><ArticleId IdType="pubmed">35872103</ArticleId></ArticleIdList></Reference><Reference><Citation>Revankar CM, Cimino DF, Sklar LA, Arterburn JB, Prossnitz ER. A transmembrane intracellular estrogen receptor mediates rapid cell signaling. Science. 2005;307:1625&#x2013;1630. doi: 10.1126/science.1106943.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1106943</ArticleId><ArticleId IdType="pubmed">15705806</ArticleId></ArticleIdList></Reference><Reference><Citation>Colasanti T, et al. Autoantibodies to estrogen receptor &#x3b1; interfere with T lymphocyte homeostasis and are associated with disease activity in systemic lupus erythematosus. Arthritis. Rheum. 2012;64:778&#x2013;787. doi: 10.1002/art.33400.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.33400</ArticleId><ArticleId IdType="pubmed">21968947</ArticleId></ArticleIdList></Reference><Reference><Citation>Dennis MK, et al. In vivo effects of a GPR30 antagonist. Nat. Chem. Biol. 2009;5:421&#x2013;427. doi: 10.1038/nchembio.168.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nchembio.168</ArticleId><ArticleId IdType="pmc">PMC2864230</ArticleId><ArticleId IdType="pubmed">19430488</ArticleId></ArticleIdList></Reference><Reference><Citation>Notas G, Kampa M, Castanas E. G protein-coupled estrogen receptor in immune cells and its role in immune-related diseases. Front. Endocrinol. 2020;11:579420. doi: 10.3389/fendo.2020.579420.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fendo.2020.579420</ArticleId><ArticleId IdType="pmc">PMC7564022</ArticleId><ArticleId IdType="pubmed">33133022</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>